NCT03319446

Brief Summary

This is a generic sample collection study for collecting blood, stool, rectal swabs, nasal washes, nasopharyngeal aspirates, nasopharyngeal swabs, throat swabs, nasal swabs, and urine from human sources. Subjects will be recruited from BioFire Diagnostics employees and from the general community. Subjects may be asked about recent or ongoing illness at the time of specimen collection and these symptoms will be recorded and attached to the sample. No other identifying information will be collected and the samples will be kept anonymous.The samples may be used internally or by external sites, such as the clinical study sites, for evaluating and determining performance characteristics of in vitro diagnostic devices.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
17mo left

Started Oct 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Oct 2017Oct 2027

Study Start

First participant enrolled

October 9, 2017

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

October 18, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 24, 2017

Completed
9.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2027

Last Updated

October 24, 2017

Status Verified

October 1, 2017

Enrollment Period

10 years

First QC Date

October 18, 2017

Last Update Submit

October 23, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • PCR Amplification Curves

    PCR amplification curves will be used to confirm the presence or absence of target analytes.

    10 years

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Employees of BioFire Diagnostics, and the general community of the greater Salt Lake City area.

You may qualify if:

  • Consenting adult

You may not qualify if:

  • Weigh less that 110 lb for blood collection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BioFire Diagnostics

Salt Lake City, Utah, 84103, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood, stool, rectal swabs, nasal washes, nasopharyngeal aspirates, nasopharyngeal swabs, throat swabs, nasal swabs, and urine from human sources.

MeSH Terms

Conditions

Respiration DisordersGastrointestinal Diseases

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesDigestive System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2017

First Posted

October 24, 2017

Study Start

October 9, 2017

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

October 1, 2027

Last Updated

October 24, 2017

Record last verified: 2017-10

Locations